{"DataElement":{"publicId":"10461897","version":"1","preferredName":"Chromosome Disorder Cytogenetic or Molecular Genetic Abnormality Or Other Abnormality Occurrence Type","preferredDefinition":"A description of the cytogenetic, molecular or other abnormalities.","longName":"CYTO_MOLE_OTH_AB_TY","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"10461890","version":"1","preferredName":"Chromosome Disorder Molecular Abnormality Or Other Abnormality Occurrence","preferredDefinition":"A disorder that results from a chromosomal abnormality.:A molecular or cytogenic abnormality which occurs in either human disease states or disease models._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Different than the one(s) previously specified or mentioned._A condition that differs from the usual physical or mental state._An instance of something happening, such as an event or incident.","longName":"10461888v1.00:10461889v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"10461888","version":"1","preferredName":"Chromosome Disorder","preferredDefinition":"A disorder that results from a chromosomal abnormality.","longName":"C34470","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chromosome Disorder","conceptCode":"C34470","definition":"A disorder that results from a chromosomal abnormality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-AC96-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-10","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"10461889","version":"1","preferredName":"Molecular Abnormality Or Other Abnormality Occurrence","preferredDefinition":"A molecular or cytogenic abnormality which occurs in either human disease states or disease models._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Different than the one(s) previously specified or mentioned._A condition that differs from the usual physical or mental state._An instance of something happening, such as an event or incident.","longName":"10461889v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Abnormality","conceptCode":"C3910","definition":"A molecular or cytogenetic abnormality which occurs in either human disease states or disease models.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Abnormality","conceptCode":"C9440","definition":"A condition that differs from the usual physical or mental state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-AC97-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-10","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-AC98-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-10","modifiedBy":"KUMMEROA","dateModified":"2022-08-22","changeDescription":null,"administrativeNotes":"2022.8.22 Released. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7412809","version":"1","preferredName":"Cytogenetic Subset Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"7412809v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"None of the above","valueDescription":"None of the Above","ValueMeaning":{"publicId":"5913672","version":"1","preferredName":"None of the Above","longName":"5913672","preferredDefinition":"None of the choices above are suitable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None of the Above","conceptCode":"C133298","definition":"None of the choices above are suitable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5499ACEF-10D1-1155-E053-F662850A3955","latestVersionIndicator":"Yes","beginDate":"2017-07-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-18","modifiedBy":"KUMMEROA","dateModified":"2022-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE81A6AF-3260-2116-E053-4EBD850A9629","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"ONEDATA","dateModified":"2020-09-04","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"3126125","version":"1","preferredName":"Other","longName":"3126125","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D01180C-814A-B8B4-E040-BB89AD432507","latestVersionIndicator":"Yes","beginDate":"2010-08-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-08-04","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":"2023.3.7 Alt VM added per ticket request CADSR0002119. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE81A6AF-326A-2116-E053-4EBD850A9629","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"ONEDATA","dateModified":"2020-09-04","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2960664","version":"1","preferredName":"Unknown","longName":"2960664","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78485FBD-4C65-D67B-E040-BB89AD432E0E","latestVersionIndicator":"Yes","beginDate":"2009-11-13","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-11-13","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE81A6AF-3274-2116-E053-4EBD850A9629","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"ONEDATA","dateModified":"2020-09-04","deletedIndicator":"No"},{"value":"t(17;19) or E2A-HLF fusion","valueDescription":"t(17;19)(q22;p13)","ValueMeaning":{"publicId":"7412811","version":"1","preferredName":"t(17;19)(q22;p13)","longName":"7412811","preferredDefinition":"No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(17;19)(q22;p13)","conceptCode":"C36361","definition":"No Value Exists","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE81A6AF-3281-2116-E053-4EBD850A9629","latestVersionIndicator":"Yes","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"KUMMEROA","dateModified":"2022-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE81A6AF-329A-2116-E053-4EBD850A9629","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"ONEDATA","dateModified":"2020-09-04","deletedIndicator":"No"},{"value":"iAMP21","valueDescription":"Intrachromosomal Amplification of Chromosome 21","ValueMeaning":{"publicId":"5094536","version":"1","preferredName":"Intrachromosomal Amplification of Chromosome 21","longName":"5094536","preferredDefinition":"A cytogenetic abnormality that refers to the allelic gain of an internal part of chromosome 21. It is a rare high-risk chromosomal abnormality that occurs in approximately 2-5% of pediatric patients with B-cell precursor Acute Lymphoblastic Leukemia. This abnormality has been associated with a poor outcome in patients treated by standard protocols.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrachromosomal Amplification of Chromosome 21","conceptCode":"C124874","definition":"A cytogenetic abnormality that refers to the allelic gain of an internal part of chromosome 21. It is a rare high-risk chromosomal abnormality that occurs in approximately 2-5% of pediatric patients with B-cell precursor Acute Lymphoblastic Leukemia. This abnormality has been associated with a poor outcome in patients treated by standard protocols.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2796F431-2C90-87F5-E050-BB89AD43578E","latestVersionIndicator":"Yes","beginDate":"2015-12-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-23","modifiedBy":"MAESKEB","dateModified":"2021-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE81A6AF-32A4-2116-E053-4EBD850A9629","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"ONEDATA","dateModified":"2020-09-04","deletedIndicator":"No"},{"value":"Ph like","valueDescription":"Philadelphia Chromosome Positive","ValueMeaning":{"publicId":"5497684","version":"1","preferredName":"Philadelphia Chromosome Positive","longName":"5497684","preferredDefinition":"Indicates that the Philadelphia chromosome abnormality, t(9;22)(q34;q11), has been detected in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Philadelphia Chromosome Positive","conceptCode":"C128843","definition":"Indicates that the Philadelphia chromosome abnormality, t(9;22)(q34;q11), has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DF8E839-83C9-2309-E053-F662850A7FBB","latestVersionIndicator":"Yes","beginDate":"2016-10-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-03","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE81A6AF-32B8-2116-E053-4EBD850A9629","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"ONEDATA","dateModified":"2020-09-04","deletedIndicator":"No"},{"value":"Ph+ [t(9;22)]","valueDescription":"t(9;22)(q34;q11)","ValueMeaning":{"publicId":"2672728","version":"1","preferredName":"t(9;22)(q34;q11)","longName":"2672728v1.00","preferredDefinition":"A translocation between chromosomes 9 and 22 that is associated with the Philadelphia chromosome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(9;22)(q34.1;q11.2)","conceptCode":"C13271","definition":"A translocation between chromosomes 9 and 22 that is associated with the Philadelphia chromosome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37BCDCA9-0A3F-297B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-15","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-15","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE81A6AF-32CC-2116-E053-4EBD850A9629","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"ONEDATA","dateModified":"2020-09-04","deletedIndicator":"No"},{"value":"Hypodiploidy","valueDescription":"Hypodiploidy","ValueMeaning":{"publicId":"3927272","version":"1","preferredName":"Hypodiploidy","longName":"3927272","preferredDefinition":"A chromosomal abnormality in which the chromosomal number is less than the normal diploid number.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypodiploidy","conceptCode":"C80337","definition":"A chromosomal abnormality in which the chromosomal number is less than the normal diploid number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9689178-AC4E-B27C-E040-BB89AD4313AB","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"KUMMEROA","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE81A6AF-32D6-2116-E053-4EBD850A9629","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"ONEDATA","dateModified":"2020-09-04","deletedIndicator":"No"},{"value":"KMT2A (11q23) rearrangement","valueDescription":"MLL Gene Rearrangement","ValueMeaning":{"publicId":"5540277","version":"1","preferredName":"MLL Gene Rearrangement","longName":"5540277","preferredDefinition":"A molecular abnormality indicating rearrangement of the MLL (KMT2A) gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KMT2A Gene Rearrangement","conceptCode":"C122623","definition":"A molecular abnormality indicating rearrangement of the KMT2A (MLL) gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FA1F895-F0FB-05B5-E053-F662850AA504","latestVersionIndicator":"Yes","beginDate":"2016-10-24","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-24","modifiedBy":"ONEDATA_WA","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE81A6AF-32EA-2116-E053-4EBD850A9629","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"ONEDATA","dateModified":"2020-09-04","deletedIndicator":"No"},{"value":"Double trisomy (+4, +10)","valueDescription":"Trisomy 10 Trisomy 4","ValueMeaning":{"publicId":"7412812","version":"1","preferredName":"Trisomy 10 Trisomy 4","longName":"7412812","preferredDefinition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 10 in somatic cells.: A chromosomal abnormality consisting of the presence of a third copy of chromosome 4 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trisomy 10","conceptCode":"C81729","definition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 10 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Trisomy 4","conceptCode":"C36530","definition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 4 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE81A6AF-32F7-2116-E053-4EBD850A9629","latestVersionIndicator":"Yes","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"KUMMEROA","dateModified":"2022-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE81A6AF-3310-2116-E053-4EBD850A9629","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"ONEDATA","dateModified":"2020-09-04","deletedIndicator":"No"},{"value":"TEL-AML1","valueDescription":"ETV6/RUNX1 Fusion Protein","ValueMeaning":{"publicId":"7412813","version":"1","preferredName":"ETV6/RUNX1 Fusion Protein","longName":"7412813","preferredDefinition":"A fusion protein encoded by the ETV6/RUNX1 fusion gene. This protein is comprised of the N-terminal DNA binding helix-loop-helix domain of the transcription factor ETV6 protein fused to nearly the entire runt-related transcription factor 1 protein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ETV6/RUNX1 Fusion Protein","conceptCode":"C18040","definition":"A fusion protein encoded by the ETV6/RUNX1 fusion gene. This protein is comprised of the N-terminal DNA binding helix-loop-helix domain of the transcription factor ETV6 protein fused to nearly the entire runt-related transcription factor 1 protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE81A6AF-331C-2116-E053-4EBD850A9629","latestVersionIndicator":"Yes","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"ONEDATA","dateModified":"2020-09-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE81A6AF-3335-2116-E053-4EBD850A9629","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"ONEDATA","dateModified":"2020-09-04","deletedIndicator":"No"},{"value":"Hyperdiploidy","valueDescription":null,"ValueMeaning":{"publicId":"3927273","version":"1","preferredName":"Hyperdiploidy","longName":"3927273","preferredDefinition":"A chromosomal abnormality in which the chromosomal number is greater than the normal diploid number.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperdiploidy","conceptCode":"C80336","definition":"A chromosomal abnormality in which the chromosomal number is greater than the normal diploid number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9689178-AC73-B27C-E040-BB89AD4313AB","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"MMADDINENI","dateModified":"2024-01-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC439F5-9665-2FB6-E053-731AD00AC155","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","deletedIndicator":"No"},{"value":"t(1;19)","valueDescription":null,"ValueMeaning":{"publicId":"3021232","version":"1","preferredName":"Chromosome 1 Chromosome 19 Chromosomal Translocation","longName":"3021232","preferredDefinition":"A cytogenetic abnormality that involves a translocation between chromosomes 1 and 19.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(1;19)","conceptCode":"C128654","definition":"A cytogenetic abnormality that involves a translocation between chromosomes 1 and 19.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8176541B-BB70-0627-E040-BB89AD431BB8","latestVersionIndicator":"Yes","beginDate":"2010-03-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-03-10","modifiedBy":"KUMMEROA","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC439F5-9666-2FB6-E053-731AD00AC155","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","deletedIndicator":"No"},{"value":"t(12;21)","valueDescription":null,"ValueMeaning":{"publicId":"3021203","version":"1","preferredName":"Chromosome 12 Chromosome 21 Chromosomal Translocation","longName":"3021203","preferredDefinition":"A cytogenetic abnormality that involves a translocation between chromosomes 12 and 21.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(12;21)","conceptCode":"C128657","definition":"A cytogenetic abnormality that involves a translocation between chromosomes 12 and 21.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81750545-2D22-1995-E040-BB89AD431CE8","latestVersionIndicator":"Yes","beginDate":"2010-03-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-03-10","modifiedBy":"KUMMEROA","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC439F5-9667-2FB6-E053-731AD00AC155","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","deletedIndicator":"No"},{"value":"complex (>3)","valueDescription":null,"ValueMeaning":{"publicId":"10383308","version":"1","preferredName":"Abnormality Greater Than or Equal To Integer Complex","longName":"10383308v1.00","preferredDefinition":"A condition that differs from the usual physical or mental state._A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways._A number with no fractional part, including the negative and positive numbers as well as zero._Hard, involved or complicated, elaborate, having many parts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormality","conceptCode":"C9440","definition":"A condition that differs from the usual physical or mental state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complex","conceptCode":"C47881","definition":"Hard, involved or complicated, elaborate, having many parts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-9662-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC439F5-9668-2FB6-E053-731AD00AC155","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","deletedIndicator":"No"},{"value":"BCR-ABL1 t(9;22)(q34;q11.2)","valueDescription":null,"ValueMeaning":{"publicId":"4787219","version":"1","preferredName":"B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1","longName":"4787219","preferredDefinition":"A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1","conceptCode":"C36312","definition":"A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13512EE0-BF1A-F3CD-E050-BB89AD432E2B","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"KUMMEROA","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC439F5-9669-2FB6-E053-731AD00AC155","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","deletedIndicator":"No"},{"value":"BCR-ABL1-like (Ph-like) ALL","valueDescription":null,"ValueMeaning":{"publicId":"4787966","version":"1","preferredName":"Ph-like","longName":"4787966","preferredDefinition":"A leukemia subtype characterized by a gene-expression profile similar to that of BCR-ABL1-positive acute lymphoblastic leukemia, alterations of lymphoid transcription factor genes, and a poor outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like","conceptCode":"C121974","definition":"B acute lymphoblastic leukemia characterized by a gene-expression profile similar to that of BCR-ABL1-positive B acute lymphoblastic leukemia, absence of the pathognomonic BCR-ABL1 rearrangement, alterations of lymphoid transcription factor genes, and a poor outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"135EEC98-D8AD-84BF-E050-BB89AD436F63","latestVersionIndicator":"Yes","beginDate":"2015-04-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-10","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC439F5-966A-2FB6-E053-731AD00AC155","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","deletedIndicator":"No"},{"value":"KMT2A (MLL)","valueDescription":null,"ValueMeaning":{"publicId":"6832290","version":"1","preferredName":"KMT2A Gene Mutation","longName":"6832290","preferredDefinition":"A change in the nucleotide sequence of the KMT2A gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MLL Gene Mutation","conceptCode":"C162513","definition":"A change in the nucleotide sequence of the MLL (KMT2A) gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E97607E-C624-075C-E053-F662850AC511","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2019-07-26","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC439F5-966B-2FB6-E053-731AD00AC155","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","deletedIndicator":"No"},{"value":"TCF3-HLF","valueDescription":null,"ValueMeaning":{"publicId":"10383309","version":"1","preferredName":"TCF3-HLF","longName":"10383309v1.00","preferredDefinition":"TCF3-HLF","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-9663-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC439F5-966C-2FB6-E053-731AD00AC155","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","deletedIndicator":"No"},{"value":"CRLF2/JAK pathway abnormalities","valueDescription":null,"ValueMeaning":{"publicId":"10383310","version":"1","preferredName":"CRLF2/JAK pathway abnormalities","longName":"10383310v1.00","preferredDefinition":"CRLF2/JAK pathway abnormalities","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-9664-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC439F5-966D-2FB6-E053-731AD00AC155","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","deletedIndicator":"No"},{"value":"tp53","valueDescription":null,"ValueMeaning":{"publicId":"4535603","version":"1","preferredName":"TP53 Gene Mutation","longName":"4535603","preferredDefinition":"A change in the nucleotide sequence of the TP53 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 Gene Mutation","conceptCode":"C118396","definition":"A change in the nucleotide sequence of the TP53 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-32D5-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC439F5-966E-2FB6-E053-731AD00AC155","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435027","version":"1","preferredName":"Gene","preferredDefinition":"A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of a protein or other product. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).","longName":"C16612","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB05-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE81A6AF-3249-2116-E053-4EBD850A9629","latestVersionIndicator":"Yes","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What were the cytogenetic, molecular or other abnormalities?","type":"Preferred Question Text","description":"What were the cytogenetic, molecular or other abnormalities?","url":null,"context":"COG"},{"name":"COG CRG Text 1","type":"Alternate Question Text","description":"Cytogenetic/molecular/other detectable abnormalities:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"ALL with cytogenetic abnormalities detected after randomization:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-7DD4-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-06-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-10","modifiedBy":"KUMMEROA","dateModified":"2022-08-22","changeDescription":null,"administrativeNotes":"2022.8.22 Released. ak","unresolvedIssues":null,"deletedIndicator":"No"}}